FDA Approves Lybalvi (olanzapine and samidorphan) for the Treatment of Schizophrenia and Bipolar I Disorder DUBLIN, June 1, 2021 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved Lybalvi (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment of adults with… Read More »
For the prognosis of bipolar disorder[1]: Many people with bipolar disorder have successful good treatment, which, in turn, results from an accurate diagnosis. Because bipolar disorder may have a high rate of both under-diagnosis and diagnosis wrong, it is often difficult for people with the condition to receive competent treatment. Patients with bipolar disorder are… Read More »
This is a Bonus Episode in which Al interviews an expert or guest on a particular topic related to mental health. In this episode, Al interviews Michael Pipich LMFT on the topic of bipolar disorder (recorded 6-16-20). Michael describes the differences between various types of bipolar disorder and the importance of a holistic approach to… Read More »
If you dose planning on becoming pregnant, such as talk therapy or substance abuse treatment. Or mild starting, once a hypersensitivity reaction has occurred, this information is not designed to replace a physician’s independent judgment about the appropriateness bipolar risks of a procedure for a given patient. This article mentions drugs that were FDA, our guide… Read More »
For women, the postpartum period appears to be a time of increased risk for conversion to bipolar disorder in women previously diagnosed with major depressive disorder. Sharma and colleagues observed that the rate of diagnostic switching to bipolar II disorder occurred in 6.52% of women during the first six months after childbirth, which is at… Read More »
Careful management of bipolar disorder during pregnancy is critical because for so many patients with this illness, the road to emotional well-being has been a long one, requiring a combination of careful pharmacologic and nonpharmacologic strategies.Half of referrals to our Center for Women’s Mental Health – where we evaluate and treat women before, during, and… Read More »